The report "Pharmaceutical Filtration Market by Product (Consumables (Membrane, Depth filter), System (Single use, Reusable)), Technique (Microfiltration, Ultrafiltration), Application (API, Protein, Vaccine), Scale of Operation (Pilot, R&D) - Global Forecast to 2029", is projected to reach USD 20.97 billion by 2029 from USD 13.31 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024 to 2029. Some factors contributing to the growth of the global market include increasing adoption of continuous manufacturing process, increasing purity requirement in pharmaceutical and biotechnology manufacturing, and growing adoption of single-use technologies. Notwithstanding this, technical limitation and high capital investments required for new production facilities are projected to impede market development.
Browse 944 market data Tables and 60 Figures spread through 645 Pages and in-depth TOC on "Pharmaceutical Filtration Market by Product (Consumables (Membrane, Depth filter), System (Single use, Reusable)), Technique (Microfiltration, Ultrafiltration), Application (API, Protein, Vaccine), Scale of Operation (Pilot, R&D) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html
The microfiltration segment accounted for the largest share of the technique segment in the pharmaceutical filtration market in 2023.
Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. Microfiltration segment dominated the market in 2023 and are expected to dominate the market in the forecast period. High growth of this segment is attributed to several factors such as increasing need of advanced filtration techniques for clarification, purification of cell broths, the separation of cell debris, and the separation of macromolecules. Additionally, growing focus on development of biopharmaceuticals is driving the need of filtration techniques resulting to boost the segment growth.
The final product processing segment dominated the pharmaceutical filtration market in 2023 and is expected to grow in coming years.
Based on application, the pharmaceutical filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing segment is further categorized as active pharmaceutical ingredient filtration, protein purification, vaccine and antibody processing, formulation and filling solutions, viral clearance. Additionally, raw material filtration segment is divided as media buffer filtration, prefiltration, bioburden testing. In 2023, final product processing accounted for major market share of pharmaceutical filtration market owing to increasing developments in biopharmaceutical industries and rising production of biologics and biopharmaceutical drugs.
North America region accounted for largest share in the pharmaceutical filtration market.
Based on the region, the oral proteins and peptides market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The North American market for pharmaceutical filtration holds major market share. The share of this market can be attributed to several key factors. Some of the factors include the strong presence of key market players offering pharmaceutical filtration products and increasing R&D spendings in biopharmaceutical industries. Additionally, growing pharmaceutical industry in the region is likely to support the growth of pharmaceutical filtration market in North America region.
Key players in the pharmaceutical filtration market include Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), 3M Company (US), Repligen Corporation (US), Parker Hannifin Corporation (US), Eaton Corporation plc (Ireland), Thermo Fisher Scientific, Inc. (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), Saint-Gobain (France), STERIS plc (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC. (US), MMS AG (Switzerland), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC (US), Filtrox AG (Switzerland), Membrane Solutions (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]